-
The FDA has approved the first transbuccal delivery system for testosterone replacement therapy in men.
-
Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimers disease.
-
Current users of estrogen or estrogen-progestin combinations were shown to have a significantly higher risk of developing and dying from breast cancer. The findings confirm and extend those published last year by the Womens Health Initiative.
-
This study demonstrated that the Stretta endoscopic radiofrequency application technique for treatment of gastroesophageal reflux disease did lead to lessened GERD-related symptoms but not to any decrease in esophageal acid exposure or medication use.
-
-
Urinary Tetrahydroaldosterone as a Screen for Primary Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis
-
Dizziness and vertigo are among the most common complaints seen by neurologists, and benign paroxysmal positional vertigo is one of their most frequent causes.
-
Even with their dependence on health maintenance organizations (HMOs), many of the nations elderly suffer from a lack of coordinated care, are often confused about their treatment - including proper use of medications - and frequently end up in the hospital for lack of proper preventive measures.
-
Here are a two frequently asked questions from the Department of Health and Human Services HIPAA web site that specifically address the types of communication that case managers and discharge planners engage in
-
To provide you with critical information on the updated regulations from the Centers for Medicare & Medicaid Services, Thomson American Health Consultants offers New EMTALA Regulations: Are They Too Good to be True? an audio conference on Tuesday, Oct. 21, from 2:30-3:30 p.m., EST.